S-Adenosyl-Methionine (Same)

Verify with FDA CVM →

33 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
33
Total Reports
5
Deaths Reported
1520.0%
Death Rate

Active Ingredients

S-Adenosyl-Methionine (Same)

Administration Routes

Oral

Species Affected

Dog 32
Cat 1

Most Affected Breeds

Chihuahua 5
Shih Tzu 3
Dachshund - Miniature 2
Shepherd Dog - German 2
Terrier - Boston 2
Siberian Husky 1
Bulldog 1
Dachshund - Standard Long-haired 1
Terrier - Kerry Blue 1
Sheepdog - Shetland 1

Most Reported Reactions

Elevated serum alkaline phosphatase (SAP) 10
Lethargy (see also Central nervous system depression in 'Neurological') 8
Decreased appetite 7
Weight loss 6
Diarrhoea 6
Elevated blood urea nitrogen (BUN) 6
Hyperkalaemia 6
Anorexia 5
Elevated creatinine 5
Shaking 4
Vomiting 4
Lack of efficacy - NOS 4

Outcome Breakdown

Outcome Unknown
20 (60.6%)
Ongoing
5 (15.2%)
Recovered/Normal
3 (9.1%)
Died
3 (9.1%)
Euthanized
2 (6.1%)

Data Summary

Metric Value
Total adverse event reports 33
Reports involving death 5
Case-fatality rate (reported events) 1520.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

S-Adenosyl-Methionine (Same) Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 33 adverse event reports referencing S-Adenosyl-Methionine (Same), including 5 reports in which the animal died — a 1520.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: S-Adenosyl-Methionine (Same). Reported administration route is Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in S-Adenosyl-Methionine (Same) reports are Dog (32 reports), Cat (1 reports), with Dog accounting for the largest share. Within those species, Chihuahua (5), Shih Tzu (3), Dachshund - Miniature (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with S-Adenosyl-Methionine (Same) are Elevated serum alkaline phosphatase (SAP) (10), Lethargy (see also Central nervous system depression in 'Neurological') (8), Decreased appetite (7), Weight loss (6). Of the 33 reports with a coded outcome, Outcome Unknown is the leading category at 60.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on S-Adenosyl-Methionine (Same).

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial